300760 迈瑞医疗
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入8,352,0161.39%33,282,15936,725,75034,931,90130,365,644
减:营业总成本5,905,26611.15%23,608,91124,096,44621,991,20519,826,760
    其中:营业成本3,184,6173.17%13,207,83813,547,51912,513,13610,885,289
               财务费用241,041-248.47%(262,908)(400,028)(854,912)(451,037)
               资产减值损失(20,815)-51.47%(335,842)(237,841)(529,506)(71,094)
公允价值变动收益1,008--486126,02879,402(21,378)
投资收益10,230-89.35%114,95369,390(9,841)(5,061)
    其中:对联营企业和合营企业的投资收益8,799211.66%15,538(11,812)(9,817)(4,698)
营业利润2,524,411-17.18%9,794,89413,111,82413,069,85810,990,515
利润总额2,541,348-16.79%9,673,96613,019,69613,010,93010,953,551
减:所得税费用114,810-68.26%1,222,4941,279,7301,432,5171,342,834
净利润2,426,538-9.88%8,451,47111,739,96711,578,4139,610,717
减:非控股权益96,88051.45%315,69671,479(3,813)3,543
股东净利润2,329,658-11.37%8,135,77511,668,48711,582,2269,607,174

市场价值指针
每股收益 (元) *1.923-11.40%6.7159.6369.5597.940
每股派息 (元) *1.250-11.35%4.3806.2705.8004.500
每股净资产 (元) *33.0823.94%31.41929.57427.28826.377
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容